A study published by David Cheng, Postdoctoral Scientist, Neuroscience Research, University of New South Wales, NSW, Australia, says that CBD has a potential as a preventive measure against symptoms of Alzheimer’s. This presents yet another exciting development for medical researchers, given the persistent challenges to finding effective solutions for this condition.
Armentano pointed to several pieces of evidence as proof that CBD has always been treated as illegal at the federal level. Congress has tried and is currently trying to pass bills to remove CBD from the Controlled Substances Act—which would be unnecessary if the compound were already legal. Further, the Controlled Substances Act itself specifies that the government has the right to control substances that are chemically similar to the ones explicitly listed.
So, why are companies allowed to lie and mislead users trying to purchase CBD products? This a result of the industry lacking formal regulation. This is very controversial because it opens the doors for big pharmaceutical companies and lobbyists to get away with practices that may prevent CBD from becoming easily accessible to those who need it. Hopefully, legislation like the 2018 Farm Bill will help establish competitive practices in the industry that will benefit the consumer in the long run.